Literature DB >> 7934613

Insulin dependent diabetes mellitus in the non-obese diabetic mouse: a disease mediated by T cell anergy?

A Jaramillo1, B M Gill, T L Delovitch.   

Abstract

The non-obese diabetic (NOD) mouse spontaneously develops autoimmune type I insulin-dependent diabetes mellitus (IDDM) with a similar immunopathological profile to the human disease. Development of the disease in both the NOD mouse and in humans is under polygenic control and influenced by many environmental factors. Diabetes results from a specific T cell-mediated destruction of pancreatic insulin-producing islet beta cells. Both CD4 and CD8 T cells as well as macrophages are required for the development of diabetes in NOD mice. An intriguing similarity between murine and human diabetes is a T cell proliferative unresponsiveness (anergy) that may be a susceptibility factor to disease onset. Defective communication between antigen-presenting cells (APC) and T cells, and/or an aberrant production or activity of inflammatory cytokines (e.g. chemokines) in the thymus and periphery (e.g. pancreas) may account for the unresponsiveness of regulatory T cells leading to a loss of immunological tolerance to beta cell autoantigens in NOD mice and in diabetic humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7934613     DOI: 10.1016/0024-3205(94)00655-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

2.  A novel role for CD4+ T cells in the control of cachexia.

Authors:  Zhuangzhi Wang; Chunfang Zhao; Rosa Moya; Joanna D Davies
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Analysis of mercury-induced immune activation in nonobese diabetic (NOD) mice.

Authors:  N Brenden; H Rabbani; M Abedi-Valugerdi
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

4.  Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.

Authors:  G A Arreaza; M J Cameron; A Jaramillo; B M Gill; D Hardy; K B Laupland; M J Rapoport; P Zucker; S Chakrabarti; S W Chensue; H Y Qin; B Singh; T L Delovitch
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

5.  Cachexia in the non-obese diabetic mouse is associated with CD4+ T-cell lymphopenia.

Authors:  Chunfang Zhao; Zhuanzhi Wang; Michael W Robertson; Joanna D Davies
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

6.  Interleukin-4-expressing plasmid DNA inhibits reovirus type-2-triggered autoimmune insulitis in DBA/1 J suckling mice.

Authors:  T Hayashi; Y Yasutomi; K Hasegawa; Y Sasaki; T Onodera
Journal:  Int J Exp Pathol       Date:  2003-04       Impact factor: 1.925

7.  Impaired plasma membrane targeting of Grb2-murine son of sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-zeta-Cbl pathway mediate T cell hyporesponsiveness in autoimmune nonobese diabetic mice.

Authors:  K Salojin; J Zhang; M Cameron; B Gill; G Arreaza; A Ochi; T L Delovitch
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

8.  Dysregulation of T lymphocyte proliferative responses in autoimmunity.

Authors:  Sydney K Elizer; Andrew F Marshall; Daniel J Moore
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.